Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of Options and Director Dealing

6 Dec 2018 07:00

RNS Number : 5599J
Surface Transforms PLC
06 December 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

Exercise of Options and Director Dealing

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.

 

Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company's total issued share capital.

 

Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

- Ends -

 

 

 

For enquiries, please contact:

Surface Transforms plc

 

 

Kevin Johnson, CEO

Michael Cunningham CFO

 

+44 151 356 2141

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

+44 20 7894 7000

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Gregor Paterson (Sales)

 

 

 

FinnCap Ltd (Joint-Broker)

+44 20 7220 0500

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

 

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Johnson

2

Reason for notification

 

 

 

a.

Position/Status

PDMR

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Surface Transforms plc

b.

LEI

213800GQHNJPE5O8XO79

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each 

ISIN: GB0002892528

b.

Nature of the transaction

Purchase of 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares).

 

c.

Price(s) and volume(s)

- Transaction 1 (Purchase)

 

- Transaction 2

(purchase)

 

Price(s)

Volume(s)

9.00p

345,000

11.5p

330,000

 

d.

Aggregated information

- Transaction 1

(purchase)

 

- Transaction 2

(purchase)

Price(s)

Aggregated volume(s)

Aggregated Total

9p

345,000

£31,050.00

11.5p

330,000

£37,950.00

 

e.

Date of the transaction

5/12/2018

f.

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGPCPUPRGWA
Date   Source Headline
17th Aug 20225:48 pmRNSExercise of options
13th Jul 20227:00 amRNSGrant of Options
6th Jul 20227:00 amRNSTrading Statement & Sales and Operations Update
30th Jun 20226:21 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Statement and Sales & Operations Presentation
21st Jun 20227:00 amRNSAdditional Capital Markets Day & Presentation
27th May 20222:46 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:58 amRNSPosting of Annual Report and Notice of AGM
10th May 202212:05 pmEQSHardman & Co: Hardman Talks Video | Surface Transforms Surface Transforms’ Capital Markets Day presentation with the Board
6th May 202210:43 amRNSPresentation to Mello Investor evening
25th Apr 20224:05 pmEQSHardman & Co Research: Surface Transforms (SCE) Growth rate and visibility enhanced even further
22nd Apr 20227:00 amRNSSurface Transforms plc Ian Cleminson appointment
11th Apr 202211:00 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms Management Presentation and Q&A
4th Apr 20227:00 amRNSPreliminary Results and Notice of AGM
31st Mar 20227:00 amRNSAdditional Capital Markets Day
24th Mar 20229:05 amRNSSecond Price Monitoring Extn
24th Mar 20229:00 amRNSPrice Monitoring Extension
24th Mar 20227:01 amRNSCapital Markets Day
24th Mar 20227:00 amRNSNew OEM 8 Contract for Additional Sales
18th Feb 20227:00 amRNSExercise of options
28th Jan 20227:00 amRNSTrading and operations update
16th Dec 202112:34 pmRNSMichael Cunningham purchase of shares
16th Dec 20217:00 amRNSAnnouncement of contract wins with OEM 6
14th Dec 20217:00 amRNSTrading and operations update
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20214:35 pmEQSHardman & Co Research : Hardman Talks Video | Surface Transforms Management Presentation
13th Sep 20217:00 amRNSHalf-year Financial Report
2nd Sep 20217:01 amRNSNew manufacturing strategy
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.